IP Library Granted Patent US 8,227,766
Granted Patent B2
US 8,227,766 · App. 12/464,855 · Granted Jul 24, 2012

Hand-held probe for intra-operative detection of fluorescence labeled compounds and antibodies

Assignee: Navidea Biopharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,227,766
App. No.
12/464,855
Granted
Jul 24, 2012
Kind
B2
Abstract

A hand-held probe for intra-operative detection of fluorescence labeled compounds includes a housing comprising a handle and a columnar portion, and a power source within the housing. A light emission source proximate the columnar portion of the housing is configured to fluoresce at least one of predetermined compounds and predetermined antibodies. An excitation switch proximate the handle selectably activates the light emission source. A detector receives fluorescent light emissions directed toward the columnar portion from at least one of the compounds and antibodies and convert the fluorescent light emissions to a corresponding emission electrical signal. A controller within the housing receives the emission electrical signal from the detector and converts the emission electrical signal to a corresponding data signal. Finally, a data port within the housing receives the data signal from the controller, converts the data signal to a corresponding output signal, and transmits the output signal.

Claims (19)

1. A fluorescence detection system, comprising:

a hand-held probe including:

a housing comprising a handle and a columnar portion;

a power source within the housing;

a light emission source proximate the columnar portion and configured to fluoresce at least one of predetermined compounds and predetermined antibodies;

an excitation switch proximate the handle to selectably activate the light emission source;

a detector to receive fluorescent light emissions directed toward the columnar portion from at least one of the compounds and antibodies and convert the fluorescent light emissions to a corresponding emission electrical signal;

a controller within the housing to receive the emission electrical signal from the detector and convert the emission electrical signal to a corresponding data signal;

a squelch switch coupled to the controller which, when actuated, causes the controller to read and store in a memory portion a baseline emission electrical signal magnitude for comparison with subsequent emission electrical signals received by the controller from the detector, emission levels having a magnitude below the stored baseline being ignored by the controller; and

a data port within the housing to receive the data signal from the controller, convert the data signal to a corresponding output signal, and transmit the output signal,

the system further including a remotely-located console to receive the output signal and provide an indication corresponding to the fluorescent light emissions.

2. The fluorescence detection system of claim 1 wherein the output signal is transmitted by wireless means.

3. The fluorescence detection system of claim 1 , further comprising an excitation filter to limit the light emitted by the light emission source to a predetermined bandwidth.

4. The fluorescence detection system of claim 1 , further comprising an emission filter to limit the light received by the detector to a predetermined wavelength.

5. The fluorescence detection system of claim 1 wherein the output signal utilizes a predetermined data protocol.

6. The fluorescence detection system of claim 1 wherein the controller is further configured to ignore emission levels exceeding the baseline but having a magnitude less than a predetermined threshold magnitude.

7. The fluorescence detection system of claim 1 wherein the controller is further configured to subtract the contribution of ambient and emission light from the fluorescent light emissions.

8. The fluorescence detection system of claim 1 wherein the indication provided by the console is one of a visually perceivable numeric indication and an aural indication, the indication being proportional to and corresponding with the magnitude of the fluorescent light emissions.

9. The fluorescence detection system of claim 1 , further comprising a status indicator mounted to the probe to provide visually perceivable information regarding the status of at least one of the power source, the data port and the remote console.

Assignments (2)
CHANGE OF NAME Recorded Jun 14, 2012
From: NEOPROBE CORP.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 028380/0558 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2009
From: CHAPMAN, GREGG J.
To: NEOPROBE CORPORATION
Reel/Frame 022683/0921 →
Continuity (2)
Provisional Application 61053470 · May 15, 2008
Related Publication 20090283698A1 · Nov 19, 2009